Peptide-Targeted Radionuclide Therapy (PTRT) using Lu-177 FAP-2286 in Diverse Adenocarcinomas: First-in-Human Results, Biodistribution and Preliminary Dosimetry Estimations

Authors :: A Höhne
A Mishra
U. Reineke
C Schuchardt
D. Müller
F. Osterkamp
A Singh
C. Smerling
A Eismant
D. Zboralski
HR Kulkarni
RP Baum
Source :: 58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin.
Publication Year :: 2020
Publisher :: © Georg Thieme Verlag KG, 2020.

Subjects :: chemistry.chemical_classification
Biodistribution
chemistry
business.industry
Targeted radionuclide therapy
Cancer research
Medicine
Dosimetry
Peptide
First in human
business

Full Text Access

Tools